BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025

  June 9, 2025

   · 

  4 min read
• Press Releases

  SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy

  June 9, 2025

   · 

  3 min read
• Press Releases

  Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season

  June 9, 2025

   · 

  6 min read
• Press Releases

  AB Science announces EMA approval of Masivet shelf-life extension to 4 years

  June 9, 2025

   · 

  3 min read
• Press Releases

  Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal Association

  June 9, 2025

   · 

  9 min read
• Press Releases

  Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy

  June 9, 2025

   · 

  11 min read
• Press Releases

  Secura Bio Announces First Patient Dosed in Phase 3 TERZO Study of COPIKTRA® (duvelisib) in Relapsed/Refractory Nodal T-follicular Helper Cell Lymphoma

  June 9, 2025

   · 

  5 min read
• Press Releases

  SEED Therapeutics Appoints Dr. Bill Desmarais as Chief Financial Officer and Chief Business Officer

  June 9, 2025

   · 

  2 min read
• Press Releases

  Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy

  June 9, 2025

   · 

  10 min read
• Press Releases

  Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia

  June 9, 2025

   · 

  7 min read